Bonno N. Bouma

11.5k total citations · 1 hit paper
188 papers, 9.1k citations indexed

About

Bonno N. Bouma is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bonno N. Bouma has authored 188 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hematology, 66 papers in Genetics and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bonno N. Bouma's work include Blood Coagulation and Thrombosis Mechanisms (104 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (62 papers) and Hemophilia Treatment and Research (40 papers). Bonno N. Bouma is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (104 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (62 papers) and Hemophilia Treatment and Research (40 papers). Bonno N. Bouma collaborates with scholars based in Netherlands, United States and Germany. Bonno N. Bouma's co-authors include Joost C.M. Meijers, Laurent O. Mosnier, John H. Griffin, Peter A. von dem Borne, Frits R. Rosendaal, Philip G. de Groot, Rogier M. Bertina, J A Koedam, Jan Rosing and J J Sixma and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Bonno N. Bouma

182 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis

2000 518 citations Joost C.M. Meijers, Bonno N. Bouma et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bonno N. Bouma Netherlands	55	5.8k	2.8k	1.2k	1.2k	1.2k	188	9.1k
Uri Seligsohn Israel	54	7.3k 1.3×	3.0k 1.1×	1.3k 1.0×	1.9k 1.6×	1.7k 1.5×	253	10.9k
Christine Mannhalter Austria	58	4.6k 0.8×	2.1k 0.7×	817 0.7×	1.9k 1.6×	1.9k 1.6×	338	10.9k
Yale Nemerson United States	58	7.9k 1.4×	2.2k 0.8×	2.1k 1.7×	1.5k 1.3×	2.2k 1.9×	145	12.7k
Maureane Hoffman United States	57	5.9k 1.0×	1.2k 0.4×	1.3k 1.1×	1.3k 1.1×	1.5k 1.3×	203	11.6k
Samuel I. Rapaport United States	46	5.1k 0.9×	1.7k 0.6×	1.5k 1.2×	760 0.6×	876 0.8×	133	8.0k
Inga Marie Nilsson Sweden	49	5.5k 0.9×	1.3k 0.5×	1.4k 1.1×	640 0.5×	608 0.5×	254	8.6k
Hau C. Kwaan United States	51	2.6k 0.5×	927 0.3×	1.4k 1.1×	1.2k 1.0×	917 0.8×	297	8.0k
Keith R. McCrae United States	56	3.7k 0.6×	1.6k 0.6×	966 0.8×	1.1k 1.0×	1.3k 1.1×	252	10.8k
Harold R. Roberts United States	50	5.3k 0.9×	1.3k 0.5×	950 0.8×	650 0.5×	899 0.8×	164	7.7k
George M. Rodgers United States	38	2.6k 0.4×	853 0.3×	521 0.4×	808 0.7×	1.0k 0.9×	187	7.2k

Countries citing papers authored by Bonno N. Bouma

Since Specialization

Citations

This map shows the geographic impact of Bonno N. Bouma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonno N. Bouma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonno N. Bouma more than expected).

Fields of papers citing papers by Bonno N. Bouma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonno N. Bouma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonno N. Bouma. The network helps show where Bonno N. Bouma may publish in the future.

Co-authorship network of co-authors of Bonno N. Bouma

This figure shows the co-authorship network connecting the top 25 collaborators of Bonno N. Bouma. A scholar is included among the top collaborators of Bonno N. Bouma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonno N. Bouma. Bonno N. Bouma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schuuring, Mark J., Arie P.J. van Dijk, Petronella G. Pieper, et al.. (2012). Bosentan treatment in mildly impaired fontan patients: a randomized controlled trial. European Heart Journal. 33. 266–266. 2 indexed citations

Bouma, Bonno N. & Jan A. van Mourik. (2006). Unraveling the mystery of von Willebrand factor. Journal of Thrombosis and Haemostasis. 4(3). 489–495. 3 indexed citations

Bouma, Bonno N., Peter A. von dem Borne, & Joost C.M. Meijers. (2005). Discovery of thrombin activatable fibrinolysis inhibitor (TAFI). Journal of Thrombosis and Haemostasis. 4(1). 257–258. 1 indexed citations

Bouma, Bonno N., et al.. (2004). New insights into factors affecting clot stability. Seminars in Hematology. 41(1). 13–19.

Mosnier, Laurent O., et al.. (2003). Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood. 101(12). 4844–4846. 92 indexed citations

Kemmeren, Jeanet M., Ale Algra, Joost C.M. Meijers, Bonno N. Bouma, & Diederick E. Grobbee. (2002). Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation. Blood Coagulation & Fibrinolysis. 13(5). 373–381. 15 indexed citations

Meijers, Joost C.M., J. Arnoud Marquart, Rogier M. Bertina, Bonno N. Bouma, & Frits R. Rosendaal. (2002). Protein C inhibitor (plasminogen activator inhibitor‐3) and the risk of venous thrombosis. British Journal of Haematology. 118(2). 604–609. 10 indexed citations

Vandenbroucke, Jan P., et al.. (2001). Oral Contraceptives and the Risk of Venous Thrombosis. New England Journal of Medicine. 344(20). 1527–1535. 385 indexed citations

Rosing, Jan, Saskia Middeldorp, Joyce Curvers, et al.. (1999). Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. The Lancet. 354(9195). 2036–2040. 193 indexed citations

10.

Meijers, Joost C.M., et al.. (1999). C4b-Binding Protein (C4BP) β-Chain Short Consensus Repeat-2 Specifically Contributes to the Interaction of C4BP with Protein S. Blood Cells Molecules and Diseases. 25(5). 279–286. 14 indexed citations

11.

Minnema, Monique C., Philip W. Friederich, Marcel Levi, et al.. (1998). Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.. Journal of Clinical Investigation. 101(1). 10–14. 159 indexed citations

12.

Chang, G T G, et al.. (1994). Studies of the Interaction between Human Protein S and Human C4b-Binding Protein Using Deletion Variants of Recombinant Human Protein S. Thrombosis and Haemostasis. 71(4). 461–467. 28 indexed citations

13.

Boer, Hetty C. de, Klaus T. Preissner, Bonno N. Bouma, & Philip G. de Groot. (1992). Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.. Journal of Biological Chemistry. 267(4). 2264–2268. 61 indexed citations

14.

Nuijens, Jan H., C C Huijbregts, A J Eerenberg-Belmer, et al.. (1989). Activation of the Contact System of Coagulation by a Monoclonal Antibody Directed Against a Neodeterminant in the Heavy Chain Region of Human Coagulation Factor XII (Hageman Factor). Journal of Biological Chemistry. 264(22). 12941–12949. 27 indexed citations

15.

Meijers, Joost C.M., Riek A. A. Vlooswijk, & Bonno N. Bouma. (1988). Inhibition of human blood coagulation factor XIa by C.hivin.1 inhibitor. Biochemistry. 27(3). 959–963. 21 indexed citations

16.

Koedam, J A, Joost C.M. Meijers, J J Sixma, & Bonno N. Bouma. (1988). Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.. Journal of Clinical Investigation. 82(4). 1236–1243. 189 indexed citations

17.

Swart, C.A.M. de, et al.. (1984). Elimination of Intravenously Administered Radiolabelled Antithrombin III and Heparin in Humans. Thrombosis and Haemostasis. 52(1). 66–70. 16 indexed citations

18.

Bouma, Bonno N., et al.. (1979). Human blood platelet factor VIII-related antigen: Demonstration of release by α-chymotrypsin. Thrombosis Research. 14(4-5). 687–696. 5 indexed citations

19.

Derkx, F. H. M., et al.. (1979). An intrinsic factor XII–prekallikrein-dependent pathway activates the human plasma renin–angiotensin system. Nature. 280(5720). 315–316. 71 indexed citations

20.

Østerud, Bjarne, Bonno N. Bouma, & John H. Griffin. (1977). Mechanism of Activation of Human Factor IX by Activated Human Factor XI. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact